UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

The New England journal of medicine, 2007-04, Vol.356 (15), p.1517-1526

2007

Link zum Volltext

Verfügbarkeit prüfen

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

Diabetes care, 2009-09, Vol.32 (9), p.1663-1668

2009

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Nature medicine, 2011-11, Vol.17 (11), p.1481-1489

2011

Link zum Volltext

Verfügbarkeit prüfen

IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction

The Journal of immunology (1950), 2011-09, Vol.187 (5), p.2755-2765

2011

Link zum Volltext

Verfügbarkeit prüfen

Cytokine production by islets in health and diabetes: cellular origin, regulation and function

Trends in endocrinology and metabolism, 2010-05, Vol.21 (5), p.261-267

2010

Link zum Volltext

Verfügbarkeit prüfen

TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6

Diabetologia, 2014-08, Vol.57 (8), p.1645-1654

2014

Link zum Volltext

Verfügbarkeit prüfen

Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I

Endocrinology (Philadelphia), 2009-12, Vol.150 (12), p.5218-5229

2009

Link zum Volltext

Verfügbarkeit prüfen

Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates

The Journal of biological chemistry, 2016-04, Vol.291 (17), p.8908-8917

2016

Link zum Volltext

Verfügbarkeit prüfen

Toll‐like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes

Immunology and cell biology, 2014-04, Vol.92 (4), p.314-323

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of β-Cell Death in Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-12, Vol.54 (suppl 2), p.S108-S113

2005

Link zum Volltext

Verfügbarkeit prüfen

Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

Diabetes (New York, N.Y.), 2007-09, Vol.56 (9), p.2356-2370

2007

Link zum Volltext

Verfügbarkeit prüfen

IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice

Diabetologia, 2015-03, Vol.58 (3), p.575-585

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 regulates pancreatic α-cell mass expansion

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.13163-13168

2008

Link zum Volltext

Verfügbarkeit prüfen

Islet Macrophages Shift to a Reparative State following Pancreatic Beta-Cell Death and Are a Major Source of Islet Insulin-like Growth Factor-1

iScience, 2020-01, Vol.23 (1), p.100775-100775, Article 100775

2020

Link zum Volltext

Verfügbarkeit prüfen

Resident Macrophages Mediate Islet Amyloid Polypeptide-Induced Islet IL-1β Production and β-Cell Dysfunction

Diabetes (New York, N.Y.), 2014-05, Vol.63 (5), p.1698-1711

2014

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

Diabetes (New York, N.Y.), 2003-03, Vol.52 (3), p.741-750

2003

Link zum Volltext

Verfügbarkeit prüfen

Macrophages, cytokines and beta-cell death in Type 2 diabetes

Biochemical Society transactions, 2008-06, Vol.36 (Pt 3), p.340

2008

Link zum Volltext

Verfügbarkeit prüfen

Regenerating 1 and 3b gene expression in the pancreas of type 2 diabetic Goto-Kakizaki (GK) rats

PloS one, 2014-02, Vol.9 (2), p.e90045-e90045

2014

Link zum Volltext

Verfügbarkeit prüfen

Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat

PloS one, 2009-09, Vol.4 (9), p.e6963-e6963

2009

Link zum Volltext

Verfügbarkeit prüfen

Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity

The Journal of immunology (1950), 2014-01, Vol.192 (2), p.623-629

2014

Link zum Volltext

Verfügbarkeit prüfen

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes

Physiology (Bethesda, Md.), 2009-12, Vol.24 (6), p.325-331

2009

Link zum Volltext

Verfügbarkeit prüfen

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Diabetes care, 2008-02, Vol.31 (2), p.S161-S164

2008

Link zum Volltext

Verfügbarkeit prüfen

Type 1, Type 1.5, and Type 2 Diabetes: NOD the Diabetes We Thought It Was

Proceedings of the National Academy of Sciences - PNAS, 2006-08, Vol.103 (33), p.12217-12218

2006

Link zum Volltext

Verfügbarkeit prüfen

Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway

The Journal of biological chemistry, 2002-10, Vol.277 (40), p.37088-37097

2002

Link zum Volltext

Verfügbarkeit prüfen

Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?

Diabetologia, 2014-03, Vol.57 (3), p.447-450

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(36)
Animals
(35)
Humans
(24)
Diabetes
(22)
Endocrinology & Metabolism
(21)
Biological And Medical Sciences
(17)
Male
(16)
Rats
(16)
Type 2 Diabetes
(15)
Inflammation
(14)
Islets Of Langerhans - Metabolism
(14)
Mice
(13)
Medical Sciences
(12)
Diabetes Mellitus, Type 2 - Metabolism
(11)
Diabetes. Impaired Glucose Tolerance
(11)
Endocrine Pancreas. Apud Cells
(11)
Endocrinopathies
(11)
Engineering
(11)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction

Cytokine production by islets in health and diabetes: cellular origin, regulation and function

TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6

Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I

Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates

Toll‐like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes

Mechanisms of β-Cell Death in Type 2 Diabetes

Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice

Interleukin-6 regulates pancreatic α-cell mass expansion

Islet Macrophages Shift to a Reparative State following Pancreatic Beta-Cell Death and Are a Major Source of Islet Insulin-like Growth Factor-1

Resident Macrophages Mediate Islet Amyloid Polypeptide-Induced Islet IL-1β Production and β-Cell Dysfunction

Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

Macrophages, cytokines and beta-cell death in Type 2 diabetes

Regenerating 1 and 3b gene expression in the pancreas of type 2 diabetic Goto-Kakizaki (GK) rats

Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat

Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Type 1, Type 1.5, and Type 2 Diabetes: NOD the Diabetes We Thought It Was

Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway

Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?

Suchergebnisse filtern